Tech Company Financing Transactions
ANEUVO Funding Round
CatcherVC and private investors participated in a $22 million Series C funding round for ANEUVO. The financing round closed on 3/5/2026.
Transaction Overview
Company Name
Announced On
3/5/2026
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series C
Investors
CatcherVC (Lead Investor)
Proceeds Purpose
Proceeds from the Series C funding will be used to: Execute commercial launch in approved markets and sales expansion; Scale manufacturing and quality systems to meet global demand; Advance U.S regulatory activities for ExaStim; Continue clinical and real-world evidence generation to drive market adoption.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10940 Wilshire Blvd. 2030
Los Angeles, CA 90024
USA
Los Angeles, CA 90024
USA
Phone
Website
Email Address
Overview
ANEUVO is a bioelectronic medical device company focused on developing advanced technology and therapies designed to help patients with diseases and injuries that have not responded to conventional medical approaches. At ANEUVO, we share a common goal: to help restore functional independence, improve quality of life, and create a healthier, more equitable world for people living with disabling diseases and conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yi-Kai Lo
Browse more venture capital transactions:
Prev: 3/5/2026: UForce venture capital transaction
Next: 3/5/2026: Greater Good Health venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs